IL2 and venous thromboembolism: While IL-2 administration can have toxic effects — including venous thromboembolism, capillary leak, and activation of effector T cell responses due to the expression of variable-affinity IL-2 receptors on endothelial, T, and NK cells (149) — low-dose IL-2 administration was well tolerated in that trial.